Arca
Skip to content
Tools
Tools

Latanoprost NDC# 82187-1002-1 Container Description: Amber colour bottle

Recall D-0264-2025, part of FDA recall event 96209. See Aspen Biopharma Labs's company page.

Aspen Biopharma Labs Pvt., Ltd. started this Class II drug recall on Feb 7, 2025 (voluntary: firm initiated); FDA lists it as ongoing.

  • Classification: Class II
  • Started: Feb 7, 2025
  • Status: Ongoing
  • Products in this event: 6

Why It Was Recalled

Class II

CGMP Deviations

Record

Product
Latanoprost NDC# 82187-1002-1 Container Description: Amber colour bottle
Quantity
150.0 gm
Lots and codes
Lot Numbers: HALAC0010123, exp. date Dec-2026 HALAC0050923, exp. date Aug-2027
Distribution
Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)
Recalling firm
Aspen Biopharma Labs Pvt., Ltd., Medchal Malkajgiri, India
How the firm notified
Letter
FDA classified
Mar 9, 2025

Other Products in This Recall

Recall event 96209

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.